An increase in gastrointestinal disorders worldwide, coupled with a growing consumer awareness towards dietary supplements, is driving the market for digestive remedies. Lifestyle changes, especially among urban populations, including consumption of processed foods and elevated stress levels, are contributing to an upswing in the prevalence of digestion-related ailments. This has...
Discover more insightsIn the past years, clinical trials for Irritable Bowel Syndrome (IBS) have seen significant innovations, illuminating new treatment paths and subsequent market opportunities. These advancements are chiefly driven by growing medical knowledge and evolving technology. Numerous novel drug candidates have entered the IBS trial stages, being designed to specifically target...
Discover more insightsAt present, the Short Bowel Syndrome (SBS) market is in an evolving stage, globally, driven by rising awareness of SBS, increasing diagnosis and treatment rates, and launching of novel, dedicated drugs. The rarity of this condition has prompted significant research and drug development efforts, facilitating market growth. Furthermore, the demand...
Discover more insightsA considerable portion of current research in gastrointestinal health is concentrated on Functional Dyspepsia (FD), a non-ulcer stomach condition causing chronic or recurring pain. This ailment affects a significant percentage of the global population, hence the importance of R&D activities in this field. The primary objective is to understand the...
Discover more insightsThe pharmaceutical industry has embarked on numerous initiatives aimed at advancing non-ulcer dyspepsia treatment. Clinical research targeting the development of more reliable and more efficient medication for functional dyspepsia is escalating at a rapid pace, aided by innovative in vivo and in vitro testing models. Furthermore, such medication seeks to...
Discover more insights